| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.30B | +61.7% |
| Cost of Revenue | $123.6M | +11.3% |
| R&D Expense | $935.2M | +113.3% |
| SG&A Expense | $451.4M | +174.2% |
| Operating Income | -$560.6M | -299.9% |
| Pre-tax Income | -$485.2M | -457.6% |
| Income Tax | -$931K | -124.5% |
| Net Income | -$484.3M | -433.2% |
| EPS (Basic) | -$3.33 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $562.1M | +40.1% |
| Accounts Receivable | $349.5M | +42.5% |
| Current Assets | $2.22B | +50.3% |
| Total Assets | $2.34B | +46.4% |
| Current Liabilities | $176.0M | +31.8% |
| Total Liabilities | $205.8M | +32.0% |
| Stockholders' Equity | $2.13B | +616.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $222.1M | +395.6% |
| Capital Expenditures | $6.2M | -35.7% |
| Investing Cash Flow | -$440.7M | -1167.3% |
| Financing Cash Flow | $379.5M | — |
| Free Cash Flow | $215.8M | +354.4% |
| -116.2% |
| EPS (Diluted) | -$3.33 | -116.2% |